Base the decision to screen for BMD on individual risk profile.
Screen for BMD among asymptomatic postmenopausal women aged 65 and older and asymptomatic men aged 75 and older.
Assess osteoporosis risk factors of premenopausal women by using a validated risk assessment tool such as FRAX.
Order BMD testing for asymptomatic postmenopausal women under age 65 if they are at increased risk on the basis of a validated risk assessment tool.
Consider screening for osteoporosis in men under age 75 with substantial risk factors.
Know that the most widely used and validated test for bone density is DXA.
Make decisions about treatment of documented osteoporosis on the basis of bone density values, the presence of prevalent vertebral fracture, and individual patient fracture risk.
Counsel all women about measures to reduce the risk for osteoporosis, including smoking cessation, maintenance of healthy body mass index, adequate calcium and vitamin D intake, and physical activity.